Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,301 | 89,137 | 60,081 | 127,677 | 59,248 |
| Marketable Securities | 334,648 | 231,428 | 215,765 | 205,611 | 235,607 |
| Receivables | 26,081 | 18,512 | 14,867 | 6,224 | 1,025 |
| Inventories | 25,753 | 18,741 | 8,624 | 2,917 | 111 |
| TOTAL | $466,916 | $374,200 | $308,268 | $354,236 | $308,387 |
| Non-Current Assets | |||||
| PPE Net | 1,104 | 632 | 1,341 | 2,197 | 2,813 |
| Intangibles | 5,319 | 6,174 | 7,028 | 7,883 | 4,658 |
| Other Non-Current Assets | 6,857 | 11,267 | 16,108 | 18,165 | 13,665 |
| TOTAL | $13,280 | $18,073 | $24,477 | $28,245 | $21,136 |
| Total Assets | $480,196 | $392,273 | $332,745 | $382,481 | $329,523 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,947 | 12,328 | 4,885 | 4,797 | 5,737 |
| Accrued Expenses | 83,855 | 62,658 | 48,262 | 32,894 | 30,084 |
| Other current liabilities | 0 | 37,704 | 0 | N/A | N/A |
| TOTAL | $105,942 | $115,517 | $55,203 | $39,809 | $43,427 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 7,490 | 2,827 | 1,286 | 1,434 | 7,000 |
| Other Non-Current Liabilities | 3,342 | 3,938 | 1,640 | 2,600 | 1,945 |
| TOTAL | $104,228 | $112,207 | $107,783 | $78,410 | $1,945 |
| Total Liabilities | $210,170 | $227,724 | $162,986 | $118,219 | $45,372 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,285 | 63,224 | 60,141 | 56,748 | 50,330 |
| Common Shares | 67 | 61 | 59 | 56 | 50 |
| Retained earnings | -1,351,877 | -1,155,338 | -894,736 | -710,058 | -528,939 |
| Other shareholders' equity | 130,161 | 142,781 | 134 | -92 | -1 |
| TOTAL | $270,026 | $164,549 | $169,759 | $264,262 | $284,151 |
| Total Liabilities And Equity | $480,196 | $392,273 | $332,745 | $382,481 | $329,523 |